Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2005
06/01/2005CN1621512A Ethanol feedback control flow added high density fermentation method for yeast and use thereof
06/01/2005CN1204259C Production process of human lysozyme as AIDS treating medicine with plant as bioreactor
06/01/2005CN1204257C New peptide fragments for protein purification
06/01/2005CN1204253C Neisseria lactoferrin binding protein
06/01/2005CN1204145C Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment
05/2005
05/31/2005US6900371 Pesticidal proteins
05/31/2005US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
05/31/2005US6900293 Monoclonal antibodies directed against the microtubule-associated protein tau
05/31/2005US6900292 Fusion protein for use in the treatment of anemia, cancer, arthritis and infections
05/31/2005US6900056 Chemically defined medium for cultured mammalian cells
05/31/2005US6900043 Phosphatases which activate map kinase pathways
05/31/2005US6900035 Comprises human papilloma virus (HPV) fusion between mycobacterial chaperone protein and viral E6 protein for use in treating tumors
05/31/2005US6900032 Human PTTG polypeptide and method for producing it
05/31/2005US6900031 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
05/31/2005US6899881 H. PYLORI FlbA POLYPEPTIDES, IMMUNOGENIC AND VACCINATING COMPOSITIONS COMPRISING H. PYLORI FlbA POLYPEPTIDES, AND COMPOSITIONS FOR DETECTION OF AN INFECTION COMPRISING H. PYLORI FlbA POLYPEPTIDES
05/31/2005US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies
05/31/2005US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition
05/31/2005CA2116221C Animal cell culture
05/26/2005WO2005047850A2 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
05/26/2005WO2005047518A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis
05/26/2005WO2005047517A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis
05/26/2005WO2005047511A2 Bacterial expression of protease inhibitors and variants thereof
05/26/2005WO2005047508A1 Processes for making acylated insulin
05/26/2005WO2005047455A2 Methods for the production of apolipoproteins in transgenic plants
05/26/2005WO2005047314A2 Fgf-beta binding and supported peptides
05/26/2005WO2005047309A2 Prophylactic and therapeutic monoclonal antibodies
05/26/2005WO2005046710A2 Tgf-beta binding and supported peptides
05/26/2005WO2005046709A2 Tgf - beta binding and supported peptides
05/26/2005WO2005046583A2 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes
05/26/2005WO2005031309A3 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways
05/26/2005WO2005021711A3 Approach for obtaining monoclonal antibodies to cell surface proteins
05/26/2005WO2005000207A3 Pcdgf receptor antibodies and methods of use thereof
05/26/2005WO2004042068A3 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
05/26/2005US20050114914 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies
05/26/2005US20050113329 Contacing cell/body fluid with antibody which binds human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide; for inhibiting tumor growth; gene expression inhibition; immunization
05/26/2005US20050113304 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
05/26/2005US20050113273 Alkaline protease from bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease
05/26/2005US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/26/2005US20050112722 Protein gene expression; high density culture
05/26/2005US20050112705 Detecting cancer perticularly of prostate gland
05/26/2005US20050112682 Green fluorescent fusion protein as diagnosis tool; quantitative analysis; colorimetic analysis
05/26/2005US20050112681 Isolated human transporter proteins, nucleic acid molecules encoding human, transporter proteins, and uses thereof
05/26/2005US20050112612 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
05/26/2005US20050112596 APRIL-A novel protein with growth effect
05/26/2005US20050112575 Nucleic acid sequence encoding polypeptides; triggering calcium oscillation in ooctyes ; determination fertility
05/26/2005US20050112574 Isolated nucleic acid; angiogenesis inhibitor
05/26/2005US20050112568 Dgks as modifiers of the p53 pathwha and methods of use
05/26/2005US20050112565 Proteases
05/26/2005US20050112556 Drug screening; endogenous human retrovirus; protein or peptide expressed by said retrovirus
05/26/2005US20050112150 Promoting exfoliation; mixture of polypeptide and protease; skin disorders; antitumor agents
05/26/2005US20050112145 Dna vaccines coding antigen
05/26/2005US20050112141 Compositions and methods for treatment of neoplastic disease
05/26/2005US20050112137 Autoantigenic fragments, methods and assays
05/26/2005US20050112127 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
05/26/2005US20050112126 Anti-VEGF antibodies
05/26/2005US20050112117 Molecules and methods for inhibiting shedding of KIM-1
05/26/2005US20050109908 Extendable/retractable support column
05/26/2005CA2545053A1 Expression in filamentous fungi of protease inhibitors and variants thereof
05/26/2005CA2544820A1 Bacterial expression of protease inhibitors and variants thereof
05/26/2005CA2544347A1 Motoneuronotrophic factor gene sequences
05/26/2005CA2544239A1 Methods for the production of apolipoproteins in transgenic plants
05/26/2005CA2542574A1 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
05/26/2005CA2530605A1 Pro104 antibody compositions and methods of use
05/25/2005EP1533380A2 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
05/25/2005EP1533379A1 G protein chimeras
05/25/2005EP1533376A1 Novel aldolases and process for producing substituted alpha-keto acid
05/25/2005EP1532446A2 G-protein coupled receptor ligands and methods
05/25/2005EP1532262A2 Petide amidation process
05/25/2005EP1532261A2 Methods and dna constructs for high yield production of polypeptides
05/25/2005EP1532251A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use
05/25/2005EP1532239A2 Methods and compositions for targeting secretory lysosomes
05/25/2005EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/25/2005EP1532174A2 Anti-igf-i receptor antibody
05/25/2005EP1532165A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
05/25/2005EP1532142A2 Polypeptide cleavage process
05/25/2005EP1531864A2 Humanized antibodies against the venezuelan equine encephalitis virus
05/25/2005EP1531836A2 Polypeptide cleavage process
05/25/2005EP1341791B1 Thioether substituted imidazoquinolines
05/25/2005EP1165615B1 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
05/25/2005EP1163335B1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
05/25/2005EP0994903B1 Methods and compositions for galactosylated glycoproteins
05/25/2005EP0871702B1 Cytokine designated lerk-7
05/25/2005EP0862461B1 Methods of treating established colitis using antibodies against il-12
05/25/2005EP0813419B1 Modulators of regulatory proteins
05/25/2005EP0688227B1 Production of human papillomavirus capsid protein and virus-like particles
05/25/2005EP0479866B2 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus
05/25/2005CN1620510A Cytokine protein family
05/25/2005CN1620507A Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
05/25/2005CN1620500A Corona-virus-like particles comprising functionally deleted genomes
05/25/2005CN1620497A Bacteria with reduced genome
05/25/2005CN1620468A Novel anti-igf-ir antibodies and uses thereof
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1620465A Process for preparing recombined placental growth factor
05/25/2005CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
05/25/2005CN1618981A Dry cell secretion factor and its preparation method and application
05/25/2005CN1618968A Production method of recombination human growth hormone
05/25/2005CN1618967A Configuration of high effect expression serum albumin yeast strain and fermentation purification technology
05/25/2005CN1618813A Human source antibody of antithyroid agent receptor mutual action protein
05/25/2005CN1618812A Human Source antibody for anti CD20 and epithelial cell adhesion molecule
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 1125